October 24, 2016
BIOPHYTIS chooses Patheon to produce the clinical batches of Macuneos, its AMD drug candidate that will enter Phase 2B. Read the Press Release
October 11, 2016
BIOPHYTIS to implement company’s SARA-data e-Health platform for clinical development of Sarconeos in sarcopenia patients. Read the Press Release
October 04, 2016
Biophytis to attend the European Large & Midcap Event in Paris – 5-6 October, 2016
September 29, 2016
Business Update and Consolidated Half-Year Financials as of June 30, 2016. Read the Press Release
September 22, 2016
BIOPHYTIS launches the second phase of Sarconeos pharmacokinetics study (SARA-PK) after successful completion of the initial phase. Read the Press Release
September 13, 2016
BIOPHYTIS ready to launch SARA-OBS trial. Read the Press Release
September 08, 2016
Biophytis will be present at BIOPHARM AMERICA 2016 in Boston, from September 13 to 15
September 05, 2016
BIOPHYTIS will present at the Rodman & Renshaw 18th Annual Global Investment Conference In New York City, September 11-13, 2016. Read the Press Release
August 26, 2016
Enrollment of the first subjects in the pharmacokinetics study on Sarcopenia. Read the Press Release
July 29, 2016
BIOPHYTIS receives approval of bpifrance for an innovation loan of €1.1M to finance the SARA-PK trial. Read the press release